Vanguard Capital Management’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
Other funds holding TCRT
Vanguard Capital Management's TCRT Position: Q3 2026 in Review
Vanguard Capital Management held its Alaunos Therapeutics (TCRT) position steady in Q3 2026 at 14,063 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4008.
Vanguard Capital Management first reported a position in TCRT in Q1 2026 and has held it in 3 quarters since. The position peaked at $40.2K in Q1 2026. 24 funds tracked by Wall St. Rank hold TCRT as of Q3 2026.
- Vanguard Capital Management held 14,063 shares of Alaunos Therapeutics worth $12.4K as of Q3 2026.
- Vanguard Capital Management left its Alaunos Therapeutics share count unchanged in Q3 2026.
- Alaunos Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #4008 holding.
- Vanguard Capital Management first reported a position in Alaunos Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Alaunos Therapeutics position peaked at $40.2K in Q1 2026.
- 24 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.